News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis Corporation (NVS) Sits in the Penalty Box


4/25/2012 8:07:17 AM

Earlier this year, I wrote a profile of Novartis and its chief executive, Joseph Jimenez, in which I detailed some of the issues hurting the company, which has traditionally been one of the stronger drug makers because of its great record of getting new medicines to market.

Read at Forbes

comments powered by Disqus
Forbes
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES